Inputs

The vehicle has been backed by Border to Coast, Islington Pension Fund and East Riding Pension Fund.

The vehicle was launched in 2024 with a $50m fundraising target.

Looser rules on new genomic techniques give crop science investors a clearer steer, but food security concerns and the push to invest closer to home may shape how far it travels.

The vehicle has a $200m fundraising target and follows on from the $260m Anterra F&A Ventures II fund.

Craig Wichner joined the Cibus board in November and says he is assuming his new role with the San Diego-headquartered gene-editing company 'at a pivot point of real opportunity'.

The Chicago-headquartered debt and equity investor’s current portfolio includes companies active in feed additives, seed industry services and farmland.

The area of land traded in Australia increased significantly in 2025, but the total value slipped, with large parcels sold in cheaper regions.

Paine Schwartz Partners’ 11-year hold of the company allowed it to create a business with ‘excellent technical and commercial expertise’ representing a ‘significant step forward’ for BASF’s biosolutions portfolio, says head of biosolutions Stefan Tresch.

Nuveen Natural Capital global head Martin Davies says factors such as a prolonged conflict or depletion of global food reserves could trigger a delayed price spike of staple commodities.

Portfolio company ATOME's Villeta project will use surplus renewable energy to produce fertilizer as the company looks to diversify global supply sources.